Leslie Boyd, MD
Gynecologic Oncology · New York, NYNPI 1497967079
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,470 of the $1,628 with a category attached, or 90.3%. AstraZeneca accounts for 94.6% of it on its own, with 2 other manufacturers making up the rest.
Across 4 payments — averaging $406.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Viiv Healthcare Company$64
- Medtronic$24
Across 19 payments — averaging $14,796 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$164K
- Seagen Inc.$118K
What the payments were for
- Consulting fees$1,47090%
- Food & beverage$15810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $1,539 |
| Viiv Healthcare Company | 1 | $64 |
| Medtronic | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$1,470
How this compares
$1,628 in reported general payments places this provider in the 60th percentile of 154 gynecologic oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in New York
- Bhavana PothuriNew York$366K
- Mario LeitaoNew York$116K
- Konstantin ZakashanskyNew York$93K
- Evelyn CantilloNew York$79K
- Farr NezhatNew York$41K
- Kristen ZeligsNew York$38K
- Nimesh NagarshethNew York$33K
- Jeff LinNew York$30K
- Valentin KolevNew York$23K
- Jason WrightNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.